Based on data from the Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023, the timeline for seeing meaningful results with retatrutide generally follows a predictable pattern, though individual responses vary considerably depending on dose, titration schedule, and personal factors
For researchers with pre-existing cardiovascular conditions, cardiac medications, or other risk factors, the heart rate increase warrants closer monitoring and slower dose escalation
Customer experience There are two key customer experience factors that Pendulum does well
What's the best tirzepatide dosing calculator
Michael Flanagan To view or add a comment, sign in A 10-minute read on the Use Case for RPM as a new enterprise to serve the pharmaceutical industry worldwide
You're not left alone with the process